ODDB.org: Open Drug Database

Orion Pharma AG - Stalevo 50/12.5/200 mg, Filmtabletten

Swissmedic Registration	56676	Sequence	01
Product name	Stalevo 50/12.5/200 mg	Description	Filmtabletten
ATC-Classification	N04BA03	ATC-Description	Levodopa, Decarboxylase Inhibitor and Comt Inhibitor
Introduction of Sequence	04.03.2004

Composition

entacaponum 200.0 mg, levodopum 50.0 mg, carbidopum 12.5 mg ut carbidopum monohydricum, maydis amylum, mannitolum, carmellosum natricum conexum corresp. natrium 1.61 mg, povidonum, magnesii stearas, Überzug: hypromellosum, saccharum 1.18 mg, E 171, E 172 (flavum), E 172 (rubrum), magnesii stearas, polysorbatum 80, glycerolum (85 per centum) pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Carbidopa	12.5 mg
Entacapone	200 mg
Levodopa	50 mg

BAG: Active Agent	Dose
Carbidopa	12.5 mg
Entacapone	200 mg
Levodopa	50 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Carmellosum Natricum Conexum
E 171		color.
E 172		color.
Glycerolum (85 per Centum) pro Compresso Obducto
Hypromellosum		Überzug
Magnesii Stearas
Mannitol
Maydis Amylum
Polysorbatum 80
Povidone
Saccharum	1.18 mg

Teilbarkeit

Teilbar		Ja
Auflösbar oder suspendierbar		kA
Zermörsebar		Ja
Öffnen von Kapseln		--
Bemerkungen / Alternativen
Quellen

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	30 Tablet(s)	20.15	38.15	B	SL	Yes
005	100 Tablet(s)	63.37	84.75	B	SL	Yes

2025	©ywesee GmbH